Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
Trial ID or NCT#
Status
Purpose
The purpose of this trial was to determine the efficacy and safety of supplemental therapeutic oxygen for infants with prethreshold retinopathy of prematurity (ROP) to reduce the probability of progression to threshold ROP and the need for peripheral retinal ablation.
Official Title
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
Eligibility Criteria
- * Infants with prethreshold retinopathy of prematurity, confirmed by 2 certified ophthalmologic exams* Median pulse oxygen saturation \<94% in room air* Median pulse oxygen saturation can be kept safely \>96% on oxygen/ventilator
- * No fatal congenital anomaly or congenital eye anomaly
Investigator(s)
View on ClinicalTrials.gov